Greene Barry E - Insider Non-Derivative Transactions at Sage Therapeutics, Inc. (SAGE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 5, 2024, Greene Barry E's relationship to Sage Therapeutics, Inc. (SAGE) is Director,Officer (President and CEO), and currently has 97,340 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SAGE insiders.
Data Source: SEC.
Greene Barry E - Insider Non-Derivative Transactions at SAGE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 6, 2024 | F -- (Common Stock) | 12273 | 8.96 | 85067 |
| Aug 6, 2024 | Acquisition -- (Common Stock) | 50400 | 0 | 97340 |